phenytoin has been researched along with Diabetes Mellitus, Type 2 in 8 studies
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study was to evaluate the effect of topical phenytoin on healing in diabetic foot ulcers." | 9.15 | The effect of topical phenytoin on healing in diabetic foot ulcers: a randomized controlled trial. ( Bell, PM; Hughes, CM; Irwin, CR; Lagan, KM; Shaw, J; Stevenson, MR, 2011) |
| "To study the impact of topical phenytoin on the healing of recalcitrant neuropathic diabetic foot ulcers in patients with no clinical evidence of ischaemia or infection, and to evaluate its antibacterial effect." | 9.14 | The impact of topical phenytoin on recalcitrant neuropathic diabetic foot ulceration. ( El-Nahas, M; Gawish, H; State, O; Tarshoby, M, 2009) |
| "The aim of the study was to evaluate the effect of topical phenytoin on healing in diabetic foot ulcers." | 5.15 | The effect of topical phenytoin on healing in diabetic foot ulcers: a randomized controlled trial. ( Bell, PM; Hughes, CM; Irwin, CR; Lagan, KM; Shaw, J; Stevenson, MR, 2011) |
| "To study the impact of topical phenytoin on the healing of recalcitrant neuropathic diabetic foot ulcers in patients with no clinical evidence of ischaemia or infection, and to evaluate its antibacterial effect." | 5.14 | The impact of topical phenytoin on recalcitrant neuropathic diabetic foot ulceration. ( El-Nahas, M; Gawish, H; State, O; Tarshoby, M, 2009) |
| "With phenytoin, there was a marginal: increase in the reduction of mean ulcer area and acceleration of effect 3rd on 4th week." | 2.70 | Topical phenytoin in diabetic ulcers: a double blind controlled trial. ( Kotian, MS; Pai, MR; Sitaraman, N, 2001) |
| "Phenytoin treatment was withdrawn, and calcitriol supplementation commenced." | 1.29 | Abnormal bone mineral metabolism after long-term anticonvulsant treatment. ( Alderman, CP; Hill, CL, 1994) |
| "Phenytoin kinetics was studied in male type I and type II diabetic patients, ten in each group." | 1.28 | Influence of type I and type II diabetes mellitus on phenytoin steady-state levels. ( Adithan, C; Bapna, JS; Indhiresan, J; Shashindran, CH; Srinivas, B; Swaminathan, RP; Thakur, LC, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Nahas, M | 1 |
| Gawish, H | 1 |
| Tarshoby, M | 1 |
| State, O | 1 |
| Shaw, J | 1 |
| Hughes, CM | 1 |
| Lagan, KM | 1 |
| Stevenson, MR | 1 |
| Irwin, CR | 1 |
| Bell, PM | 1 |
| Pai, MR | 1 |
| Sitaraman, N | 1 |
| Kotian, MS | 1 |
| Alderman, CP | 1 |
| Hill, CL | 1 |
| Yamada, N | 1 |
| Kaneko, K | 1 |
| Saito, Y | 1 |
| Tatsuno, I | 1 |
| Adithan, C | 1 |
| Srinivas, B | 1 |
| Indhiresan, J | 1 |
| Shashindran, CH | 1 |
| Bapna, JS | 1 |
| Thakur, LC | 1 |
| Swaminathan, RP | 1 |
| Mak, KH | 1 |
| Chee, M | 1 |
| Kostic, BA | 1 |
| Olsen, KM | 1 |
| Kearns, GL | 1 |
| Kemp, SF | 1 |
3 trials available for phenytoin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
The impact of topical phenytoin on recalcitrant neuropathic diabetic foot ulceration.
Topics: Administration, Cutaneous; Bandages; Debridement; Diabetes Mellitus, Type 2; Diabetic Foot; Egypt; F | 2009 |
The effect of topical phenytoin on healing in diabetic foot ulcers: a randomized controlled trial.
Topics: Administration, Cutaneous; Body Mass Index; Dermatologic Agents; Diabetes Mellitus, Type 1; Diabetes | 2011 |
Topical phenytoin in diabetic ulcers: a double blind controlled trial.
Topics: Administration, Topical; Adult; Aged; Diabetes Mellitus, Type 2; Diabetic Foot; Double-Blind Method; | 2001 |
5 other studies available for phenytoin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Abnormal bone mineral metabolism after long-term anticonvulsant treatment.
Topics: Aged; Aged, 80 and over; Bone Density; Calcifediol; Diabetes Mellitus, Type 2; Epilepsy, Tonic-Cloni | 1994 |
Anticonvulsant hypersensitivity syndrome with marked eosinophilia in treatment of diabetic neuropathy.
Topics: Adult; Anticonvulsants; Carbamazepine; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Drug Hypers | 2002 |
Influence of type I and type II diabetes mellitus on phenytoin steady-state levels.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Hum | 1991 |
Focal seizure in non-ketotic hyperglycaemia.
Topics: Aged; Blood Glucose; Brain Diseases; Diabetes Mellitus, Type 2; Epilepsies, Partial; Female; Humans; | 1990 |
Effect of glycated albumin on phenytoin binding in elderly patients with type II diabetes mellitus.
Topics: Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Glycated Serum Albumin; Glycation End Pr | 1990 |